Stocktoria
Astrana Health, Inc. ASTH
Nasdaq · stock · Services-Management Consulting Services · website · IPO 1999-04-09
Astrana Health, Inc. financials (annual)
Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.2B | $2.0B | $1.4B | $1.1B | $773.9M | $687.2M | $560.6M | $519.9M | $357.7M | $57.4M |
| Operating income | $78.5M | $89.3M | $84.6M | $104.3M | $98.2M | $80.5M | $32.4M | $88.4M | $35.1M | -$10.5M |
| Interest expense | — | — | $16.1M | $7.9M | $5.4M | $9.5M | $4.7M | $561,000 | $79,689 | $82,905 |
| Income tax | $15.5M | $30.9M | $32.0M | $40.9M | $31.7M | $56.1M | $8.2M | $22.4M | $3.9M | -$47,495 |
| Net income | $22.5M | $43.1M | $60.7M | $45.2M | $68.9M | $37.9M | $14.1M | $10.8M | $25.8M | -$9.0M |
| EPS (diluted) | $0.46 | $0.90 | $1.29 | $0.99 | $1.52 | $1.01 | $0.39 | $0.29 | $0.90 | — |
| Operating cash flow | $114.6M | $52.2M | $68.2M | $82.1M | $70.3M | $46.2M | $13.7M | $25.5M | $51.8M | -$8.1M |
| Free cash flow | $104.5M | $44.2M | $39.7M | $59.2M | $51.1M | $45.0M | $12.6M | $24.3M | $49.7M | -$8.4M |
| Cash & equivalents | $429.5M | $288.5M | $293.8M | $288.0M | $233.1M | $193.5M | $103.2M | $106.9M | $99.7M | $63.3M |
| Total assets | $2.2B | $1.4B | $933.4M | $966.2M | $852.4M | $817.5M | $728.7M | $513.0M | $490.6M | $20.6M |
| Total liabilities | $1.7B | $840.7M | $522.6M | $407.7M | $336.4M | $372.3M | $367.7M | $106.3M | $154.3M | $20.4M |
| Shareholders' equity | $793.3M | $716.7M | $616.7M | $544.3M | $454.6M | $330.8M | $192.3M | $181.5M | $164.2M | -$353,877 |
Growth · year-over-year · Revenue CAGR 56.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +56.4% | +46.7% | +21.2% | +47.8% | +12.6% | +22.6% | +7.8% | +45.3% | +523.0% | -81.2% |
| Net income growth | -47.9% | -28.9% | +34.4% | -34.5% | +82.0% | +168.2% | +30.3% | -58.0% | — | -178.3% |
| EPS growth | -48.9% | -30.2% | +30.3% | -34.9% | +50.5% | +159.0% | +34.5% | -67.8% | — | — |
| Free cash flow growth | +136.6% | +11.3% | -32.9% | +15.8% | +13.6% | +256.3% | -48.1% | -51.1% | — | -145.3% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.